Form 4 holding
FINANCIAL OFFICER, (PFO & PAO)
Bellerophon Therapeutics, Inc.
- Security class
- Stock Options (right to buy)
- Shares / value
- 50,000
- Estimated value
- $155,000
- Report date
- 10 Feb 2023
- Price
- $3.10
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount